Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2012-03, Vol.56 (3), p.1253-1257 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1257 |
---|---|
container_issue | 3 |
container_start_page | 1253 |
container_title | Antimicrobial Agents and Chemotherapy |
container_volume | 56 |
creator | Werngren, J Sturegård, E Juréen, P Ängeby, K Hoffner, S Schön, T |
description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
doi_str_mv | 10.1128/AAC.05894-11 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3294906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>922214723</sourcerecordid><originalsourceid>FETCH-LOGICAL-a542t-dd4b16704f19aac852fd9f6aebea2583f56aa283043e2bf248bfff8c387c224f3</originalsourceid><addsrcrecordid>eNp1ksFu1DAQhiMEokvhxhmZA0JIpDh27DgXpFUKpdJWILoVR8txxruuss5iO62WJ-Px8JKl0AOHkWXNN__YM3-WPS_wSVEQ8W4-b04wE3WZF8WDbFbgWuSc1fxhNsOY87wUuDzKnoRwjdOd1fhxdkQIwZSJapb9_Apwo_pRRTs4NBgU14Aab6PVqkfN4DS46KesGTw69eMKXY5Bwzba1vY27tASQrRuta--2OmhVTqCt-MGxbEFr8d-CDYgtVLWhYi-7Lz6YZ3a2A7QVdgXfrN9ly93W0AX5w06tSF62477nqnMdWjr9BydgQN0Cd9HcDoVPc0eGdUHeHY4j7Orjx-Wzad88fnsvJkvcsVKEvOuK9uCV7g0Ra2UFoyYrjZcQQuKMEEN40oRQXFJgbSGlKI1xghNRaUJKQ09zhaTbriF7djKrbcb5XdyUFb24zZFm0IGkEAZpAkbSThhsuS4kq2ptFSVqYQCoWsuktz7SS5pbaCbptvfU72fcXYtV8ONpKQua8yTwOuDgB_SLEKUG5u20ffKwTAGWafdFmVFaCLfTqT2QwgezF2XAsu9dWSyjvxtnXRN-JsJV2FD5PUwepfm-j_2xb-_uBP-46sEvDoAKiQjGa_S0sJfjjFWUb5_48uJW9vV-tZ6kKm7TIuSjEsqC8Io_QUl5ukl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>922214723</pqid></control><display><type>article</type><title>Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Werngren, J ; Sturegård, E ; Juréen, P ; Ängeby, K ; Hoffner, S ; Schön, T</creator><creatorcontrib>Werngren, J ; Sturegård, E ; Juréen, P ; Ängeby, K ; Hoffner, S ; Schön, T</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>ISSN: 1098-6596</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.05894-11</identifier><identifier>PMID: 22203587</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Amidohydrolases ; Amidohydrolases - genetics ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antitubercular Agents ; Antitubercular Agents - pharmacology ; Basic Medicine ; Biological and medical sciences ; Drug Resistance, Bacterial ; Genotype ; Humans ; Hydrogen-Ion Concentration ; Medical and Health Sciences ; Medical sciences ; Medicin och hälsovetenskap ; Medicinska och farmaceutiska grundvetenskaper ; Microbial Sensitivity Tests ; Microbiology in the medical area ; Mikrobiologi inom det medicinska området ; Mutation ; Mycobacterium tuberculosis ; Mycobacterium tuberculosis - drug effects ; Mycobacterium tuberculosis - growth & development ; Mycobacterium tuberculosis - isolation & purification ; Pharmacology. Drug treatments ; Pyrazinamide ; Pyrazinamide - pharmacology ; Reproducibility of Results ; Sequence Analysis, DNA ; Susceptibility ; Tuberculosis, Multidrug-Resistant - microbiology</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2012-03, Vol.56 (3), p.1253-1257</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved.</rights><rights>Copyright © 2012, American Society for Microbiology. All Rights Reserved. 2012 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a542t-dd4b16704f19aac852fd9f6aebea2583f56aa283043e2bf248bfff8c387c224f3</citedby><cites>FETCH-LOGICAL-a542t-dd4b16704f19aac852fd9f6aebea2583f56aa283043e2bf248bfff8c387c224f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294906/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294906/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25557363$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22203587$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://lup.lub.lu.se/record/2379146$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Werngren, J</creatorcontrib><creatorcontrib>Sturegård, E</creatorcontrib><creatorcontrib>Juréen, P</creatorcontrib><creatorcontrib>Ängeby, K</creatorcontrib><creatorcontrib>Hoffner, S</creatorcontrib><creatorcontrib>Schön, T</creatorcontrib><title>Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Amidohydrolases</subject><subject>Amidohydrolases - genetics</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antitubercular Agents</subject><subject>Antitubercular Agents - pharmacology</subject><subject>Basic Medicine</subject><subject>Biological and medical sciences</subject><subject>Drug Resistance, Bacterial</subject><subject>Genotype</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Medical and Health Sciences</subject><subject>Medical sciences</subject><subject>Medicin och hälsovetenskap</subject><subject>Medicinska och farmaceutiska grundvetenskaper</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology in the medical area</subject><subject>Mikrobiologi inom det medicinska området</subject><subject>Mutation</subject><subject>Mycobacterium tuberculosis</subject><subject>Mycobacterium tuberculosis - drug effects</subject><subject>Mycobacterium tuberculosis - growth & development</subject><subject>Mycobacterium tuberculosis - isolation & purification</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyrazinamide</subject><subject>Pyrazinamide - pharmacology</subject><subject>Reproducibility of Results</subject><subject>Sequence Analysis, DNA</subject><subject>Susceptibility</subject><subject>Tuberculosis, Multidrug-Resistant - microbiology</subject><issn>0066-4804</issn><issn>1098-6596</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1ksFu1DAQhiMEokvhxhmZA0JIpDh27DgXpFUKpdJWILoVR8txxruuss5iO62WJ-Px8JKl0AOHkWXNN__YM3-WPS_wSVEQ8W4-b04wE3WZF8WDbFbgWuSc1fxhNsOY87wUuDzKnoRwjdOd1fhxdkQIwZSJapb9_Apwo_pRRTs4NBgU14Aab6PVqkfN4DS46KesGTw69eMKXY5Bwzba1vY27tASQrRuta--2OmhVTqCt-MGxbEFr8d-CDYgtVLWhYi-7Lz6YZ3a2A7QVdgXfrN9ly93W0AX5w06tSF62477nqnMdWjr9BydgQN0Cd9HcDoVPc0eGdUHeHY4j7Orjx-Wzad88fnsvJkvcsVKEvOuK9uCV7g0Ra2UFoyYrjZcQQuKMEEN40oRQXFJgbSGlKI1xghNRaUJKQ09zhaTbriF7djKrbcb5XdyUFb24zZFm0IGkEAZpAkbSThhsuS4kq2ptFSVqYQCoWsuktz7SS5pbaCbptvfU72fcXYtV8ONpKQua8yTwOuDgB_SLEKUG5u20ffKwTAGWafdFmVFaCLfTqT2QwgezF2XAsu9dWSyjvxtnXRN-JsJV2FD5PUwepfm-j_2xb-_uBP-46sEvDoAKiQjGa_S0sJfjjFWUb5_48uJW9vV-tZ6kKm7TIuSjEsqC8Io_QUl5ukl</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Werngren, J</creator><creator>Sturegård, E</creator><creator>Juréen, P</creator><creator>Ängeby, K</creator><creator>Hoffner, S</creator><creator>Schön, T</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D95</scope></search><sort><creationdate>20120301</creationdate><title>Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing</title><author>Werngren, J ; Sturegård, E ; Juréen, P ; Ängeby, K ; Hoffner, S ; Schön, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a542t-dd4b16704f19aac852fd9f6aebea2583f56aa283043e2bf248bfff8c387c224f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Amidohydrolases</topic><topic>Amidohydrolases - genetics</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antitubercular Agents</topic><topic>Antitubercular Agents - pharmacology</topic><topic>Basic Medicine</topic><topic>Biological and medical sciences</topic><topic>Drug Resistance, Bacterial</topic><topic>Genotype</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Medical and Health Sciences</topic><topic>Medical sciences</topic><topic>Medicin och hälsovetenskap</topic><topic>Medicinska och farmaceutiska grundvetenskaper</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology in the medical area</topic><topic>Mikrobiologi inom det medicinska området</topic><topic>Mutation</topic><topic>Mycobacterium tuberculosis</topic><topic>Mycobacterium tuberculosis - drug effects</topic><topic>Mycobacterium tuberculosis - growth & development</topic><topic>Mycobacterium tuberculosis - isolation & purification</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyrazinamide</topic><topic>Pyrazinamide - pharmacology</topic><topic>Reproducibility of Results</topic><topic>Sequence Analysis, DNA</topic><topic>Susceptibility</topic><topic>Tuberculosis, Multidrug-Resistant - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Werngren, J</creatorcontrib><creatorcontrib>Sturegård, E</creatorcontrib><creatorcontrib>Juréen, P</creatorcontrib><creatorcontrib>Ängeby, K</creatorcontrib><creatorcontrib>Hoffner, S</creatorcontrib><creatorcontrib>Schön, T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Lunds universitet</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Werngren, J</au><au>Sturegård, E</au><au>Juréen, P</au><au>Ängeby, K</au><au>Hoffner, S</au><au>Schön, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>56</volume><issue>3</issue><spage>1253</spage><epage>1257</epage><pages>1253-1257</pages><issn>0066-4804</issn><issn>1098-6596</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>22203587</pmid><doi>10.1128/AAC.05894-11</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0066-4804 |
ispartof | Antimicrobial Agents and Chemotherapy, 2012-03, Vol.56 (3), p.1253-1257 |
issn | 0066-4804 1098-6596 1098-6596 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3294906 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Amidohydrolases Amidohydrolases - genetics Antibiotics. Antiinfectious agents. Antiparasitic agents Antitubercular Agents Antitubercular Agents - pharmacology Basic Medicine Biological and medical sciences Drug Resistance, Bacterial Genotype Humans Hydrogen-Ion Concentration Medical and Health Sciences Medical sciences Medicin och hälsovetenskap Medicinska och farmaceutiska grundvetenskaper Microbial Sensitivity Tests Microbiology in the medical area Mikrobiologi inom det medicinska området Mutation Mycobacterium tuberculosis Mycobacterium tuberculosis - drug effects Mycobacterium tuberculosis - growth & development Mycobacterium tuberculosis - isolation & purification Pharmacology. Drug treatments Pyrazinamide Pyrazinamide - pharmacology Reproducibility of Results Sequence Analysis, DNA Susceptibility Tuberculosis, Multidrug-Resistant - microbiology |
title | Reevaluation of the Critical Concentration for Drug Susceptibility Testing of Mycobacterium tuberculosis against Pyrazinamide Using Wild-Type MIC Distributions and pncA Gene Sequencing |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T09%3A22%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reevaluation%20of%20the%20Critical%20Concentration%20for%20Drug%20Susceptibility%20Testing%20of%20Mycobacterium%20tuberculosis%20against%20Pyrazinamide%20Using%20Wild-Type%20MIC%20Distributions%20and%20pncA%20Gene%20Sequencing&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=Werngren,%20J&rft.date=2012-03-01&rft.volume=56&rft.issue=3&rft.spage=1253&rft.epage=1257&rft.pages=1253-1257&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.05894-11&rft_dat=%3Cproquest_pubme%3E922214723%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=922214723&rft_id=info:pmid/22203587&rfr_iscdi=true |